Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) this week unveiled a significant new deal that promises to elevate its commodity diversification efforts to a new level. It is acquiring an interest in a copper revenue stream in the Moxico Resources' Mimbula copper mine in Zambia, which is set to undergo an expansion and ramp up in production CEO Marc Bishop Lafleche joined the Proactive studio, and told us that the $50 million transaction aligns with Ecora's strategy of focusing on royalties and streams over producing mines, contributing to immediate earnings and cash flow growth.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has acquired a copper stream from Moxico Resources' Mimbula copper mine in Zambia for $50 million. The stream covers the mine's 11-year Life of Mine (LOM) with potential for extension.
electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) reported portfolio income of US$63 million for 2024 was slightly higher than market estimates, says broker Peel Hunt. Management highlighted that the contingent consideration of US$5m from Narrabri has started to be received, with US$3m reaching Ecora's bank accounts in January, significantly sooner than we had expected.
Royalty specialist Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) said its income in its fourth quarter was boosted by record production volumes at the Voisey's Bay (cobalt) and Mantos Blancos (copper). As a result, income from its portfolio rose 29% to US$6.7 million in the quarter from the same period a year ago.
If you are looking for stocks that are well positioned to maintain their recent uptrend, electroCore (ECOR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
electroCore, Inc. (ECOR) shows promising growth with a 45% YoY revenue increase and a 38% loss reduction, despite missing revenue expectations. The company's gammaCore device is FDA-cleared for headaches, and expanding product lines indicate strong potential and barriers to entry. Management is focused on profitability, rather than international expansion, with high gross margins and decreasing OPEX as a percentage of revenue.
electroCore's gammaCore, an FDA-approved nVNS device, generates recurring revenue and has significant expansion potential within the VA system and other healthcare channels. The company is diversifying with the rugged TAC-STIM for military use and the consumer-focused Truvaga Plus, targeting wellness markets. The recent acquisition of NeuroMetrix's Quell system for fibromyalgia offers revenue and cost synergies, leveraging electroCore's established sales channels.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) provided investors with a general update on its royalty and stream portfolio projects, as well as news that the company will join the FTSE UK SmallCap Index and the FTSE UK All-Share Index, effective 23 December 2024. Of its three producing royalties, the company recalled that Vale Base Metals has completed the Voisey's Bay mine expansion project, transitioning operations from open pit to underground mining.
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has noted yesterday's confirmation from operator Vale that it had completed the Voisey's Bay Mine Expansion Project. Royalty specialist Ecora has a stream agreement which entitles it to 22.82% of all cobalt production from the Voisey's Bay mine up to 7,600t of finished cobalt, after which the percentage drops to 11.41%.
electroCore, Inc. (NASDAQ:ECOR ) Q3 2024 Earnings Call Transcript November 13, 2024 4:30 PM ET Company Participants Dan Goldberger - CEO & Director Joshua Lev - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the electroCore Third Quarter 2024 Earnings Conference Call.
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.68 per share a year ago.